Stay updated on Pralsetinib in RET+ Cancer Clinical Trial

Sign up to get notified when there's something new on the Pralsetinib in RET+ Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pralsetinib in RET+ Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The update shows recruitment has ended by displaying 'No longer looking for participants,' and adds help/navigation items such as 'How to Read a Study Record,' 'Common Questions,' and 'How to Join a Study,' along with minor label/version changes to 'Intervention/Treatment' and revision tags.
    Difference
    0.2%
    Check dated 2026-06-15T08:30:44.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    Revision tag on the page changed from v3.5.4 to v3.5.5. This indicates a minor system update to the ClinicalTrials.gov page rather than changes to the study details.
    Difference
    0.0%
    Check dated 2026-06-08T04:17:16.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.4, replacing the previous Revision: v3.5.3, indicating a minor platform update to the page without changing its content.
    Difference
    0.0%
    Check dated 2026-05-17T10:42:25.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    Adds a citation to NCCN Guidelines: Thyroid Carcinoma, Version 1.2025 (J Natl Compr Canc Netw. 2025). This reference provides guideline context for thyroid cancer management without altering the study’s core content.
    Difference
    0.0%
    Check dated 2026-05-10T11:02:38.000Z thumbnail image
  7. Check
    47 days ago
    Change Detected
    Summary
    A new final ARROW study article on pralsetinib in RET-altered solid tumors was added to Publications (J Clin Oncol, May 2026) with DOI 10.1200/JCO-25-01489. The previous online-ahead-of-print citation for this article was removed.
    Difference
    0.0%
    Check dated 2026-05-03T01:54:14.000Z thumbnail image
  8. Check
    55 days ago
    Change Detected
    Summary
    The page’s displayed revision/version in the footer was updated from v3.5.2 to v3.5.3, indicating a technical update to the site interface rather than a change to the trial record.
    Difference
    0.0%
    Check dated 2026-04-25T18:45:41.000Z thumbnail image

Stay in the know with updates to Pralsetinib in RET+ Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pralsetinib in RET+ Cancer Clinical Trial page.